Similar articles

• Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.

  Crocker A, España RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, Honda M, Mignot E, Scammell TE. Crocker A, et al. Neurology. 2005 Oct 25;65(8):1184-8. doi: 10.1212/01.wnl.0000168173.71940.ab. Epub 2005 Sep 14. Neurology. 2005. PMID: 16247044 Free PMC article.
• Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.

  Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM. Blouin AM, et al. Neurology. 2005 Oct 25;65(8):1189-92. doi: 10.1212/01.wnl.0000175219.01544.c8. Epub 2005 Aug 31. Neurology. 2005. PMID: 16135770 Free PMC article.
• Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.

  Nishino S, Kanbayashi T. Nishino S, et al. Sleep Med Rev. 2005 Aug;9(4):269-310. doi: 10.1016/j.smrv.2005.03.004. Sleep Med Rev. 2005. PMID: 16006155 Review.
• The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.

  Zeitzer JM, Nishino S, Mignot E. Zeitzer JM, et al. Trends Pharmacol Sci. 2006 Jul;27(7):368-74. doi: 10.1016/j.tips.2006.05.006. Trends Pharmacol Sci. 2006. PMID: 16766052 Review.
• Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.

  Baumann CR, Stocker R, Imhof HG, Trentz O, Hersberger M, Mignot E, Bassetti CL. Baumann CR, et al. Neurology. 2005 Jul 12;65(1):147-9. doi: 10.1212/01.wnl.0000167605.02541.f2. Neurology. 2005. PMID: 16009905